Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Activity of [Des-Aspartyl1]-Angiotensin II and Angiotensin II in Man: DIFFERENCES IN BLOOD PRESSURE AND ADRENOCORTICAL RESPONSES DURING NORMAL AND LOW SODIUM INTAKE
Robert M. Carey, … , Michael J. Peach, Carlos R. Ayers
Robert M. Carey, … , Michael J. Peach, Carlos R. Ayers
Published January 1, 1978
Citation Information: J Clin Invest. 1978;61(1):20-31. https://doi.org/10.1172/JCI108919.
View: Text | PDF

Activity of [Des-Aspartyl1]-Angiotensin II and Angiotensin II in Man: DIFFERENCES IN BLOOD PRESSURE AND ADRENOCORTICAL RESPONSES DURING NORMAL AND LOW SODIUM INTAKE

  • Text
  • PDF
Abstract

This study was designed to compare the effect of [des-Aspartyl1]-angiotensin II ([des-Asp]-A II) and angiotensin II (A II) on blood pressure and aldosterone production in man under conditions of normal and low sodium (Na) intake. Seven normal male subjects in balance on constant normal Na intake (UNa V 160.3±5.0 meq/24 h) for 5 days received A II and [des-Asp]-A II infusions on two consecutive days; 1 mo later they were restudied after 5 days of low Na intake (UNa V 10.5±1.6 meq/24 h). Each dose was infused for 30 min, sequentially. During normal Na intake, [des-Asp]-A II from 2 to 18 pmol/kg per min increased mean blood pressure from 85.2±3 to 95.3±5 mm Hg and plasma aldosterone concentration from 5.2±1.1 to 14.3±1.9 ng/100 ml. During low Na intake, the same dose of [des-Asp]-A II increased mean blood pressure from 83.7±3 to 86.7±3 mm Hg and plasma aldosterone concentration from 34.4±6.0 to 51.0±8.2 ng/100 ml. In contrast, A II from 2 to 6 pmol/kg per min during normal Na intake increased mean blood pressure from 83.3±4 to 102.3±4 mm Hg and plasma aldosterone concentration from 7.0±2.2 to 26.8±2.0 ng/100 ml; during low Na intake, A II increased mean blood pressure from 83.0±3 to 96.0±4 mm Hg and plasma aldosterone concentration from 42.0±9.7 to 102.2±15.4 ng/100 ml. A II and [des-Asp]-A II were equally effective in suppressing renin release. Plasma cortisol and Na and K concentration did not change.

Authors

Robert M. Carey, E. Darracott Vaughan Jr., Michael J. Peach, Carlos R. Ayers

×

Total citations by year

Year: 2017 2014 2000 1998 1997 1991 1990 1989 1988 1986 1985 1984 1983 1982 1981 1980 1979 Total
Citations: 1 1 1 2 1 1 1 1 2 1 1 3 3 2 1 2 3 27
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (27)

Title and authors Publication Year
The vasoprotective axes of the renin-angiotensin system: physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney diseases
XC Li, J Zhang, JL Zhuo
Pharmacological Research 2017
Comprehensive Physiology
SN Cheuvront, RW Kenefick
Comprehensive Physiology 2014
Angiotensin Antagonists
MJ Robertson
Journal of Receptors and Signal Transduction 2000
Angiotensin-(1–7): a bioactive fragment of the renin–angiotensin system1100 years of Renin.1
CM Ferrario, SN Iyer
Regulatory Peptides 1998
Angiotensin and Blood Pressure Regulation
FA Mendelsohn, R Quirion, AM Allen, G Aguilera, MA Millan, KJ Catt
Angiotensin and Blood Pressure Regulation 1998
Angiotensin II Has Depressor Effects in Pregnant and Nonpregnant Women
FB Pipkin, PN Baker
Hypertension 1997
Effects of atrial natriuretic peptide and angiotensin III on the uptake and intracellular distribution of norepinephrine in medulla oblongata of the rat
MS Vatta, LG Bianciotti, ML Papouchado, AS Locatelli, BE Fernández
Comparative Biochemistry and Physiology Part C: Comparative Pharmacology 1991
Selective peripheral dopamine-1 receptor stimulation. Differential responses to sodium loading and depletion in humans
NV Ragsdale, M Lynd, RL Chevalier, RA Felder, MJ Peach, RM Carey
Hypertension 1990
Medical Treatment of Low-Renin Aldosteronism
Y Shenker
Endocrinology and metabolism clinics of North America 1989
Inhibition of the aldosterone response to sodium depletion in man by stimulation of dopamine DA2 receptors
C Lombardi, C Missale, RD Cotiis, C Spedini, G Pizzoccolo, M Memo, A Albertini, PF Spano
European Journal of Clinical Pharmacology 1988
The Adrenal Gland
CR Kannan
1988
Proceedings of the 1985 Laurentian Hormone Conference
RM Carey, S Sen
Proceedings of the 1985 Laurentian Hormone Conference 1986
Relative biological activities of Asn1-, Val5-angiotensin II, Ile5-angiotensin II and Sar1-angiotensin II in man
T Kono, A Taniguchi, H Imura, F Oseko, MC Khosla
Life Sciences 1985
Identification of the angiotensin II receptor in rat mesenteric artery
J McQueen, GD Murray, PF Semple
Biochemical Journal 1984
Idiopathic Hyperaldosteronism: A Possible Role for Aldosterone-Stimulating Factor
RM Carey, S Sen, LM Dolan, CD Malchoff, FM Bumpus
New England Journal of Medicine 1984
Dopaminergic suppression of angiotensin II-induced aldosterone secretion in man: Differential responses during sodium loading and depletion
CR Drake, NV Ragsdale, DL Kaiser, RM Carey
Metabolism 1984
Cytochemical Bioassays
JC Jones, J Alaghband-Zadeh, GA MacGregor
Cytochemical Bioassays 1983
Biological activity of des-(Asp1, Arg2, Val3)-angiotensin II in man
T Kono, F Oseko, F Ikeda, R Nakano, A Taniguchi, H Imura, MC Khosla
Life Sciences 1983
Mineralocorticoids and Hypertension
W Kaufmann, G Wambach, A Helber, KA Meurer
1983
Effects of Angiotensin III and Acth on Aldosterone Secretion
PG Zager, JA Luetscher, PG Zager, JA Luetscher
Clinical and Experimental Hypertension 1982
Angiotensin II receptors on human platelets
TJ Moore, GH Williams
Circulation research 1982
Regulation of vascular angiotensin II receptors in the rat during altered sodium intake
G Aguilera, K Catt
Circulation research 1981
[DES-ASP1] angiotensin II in the sheep: Blood levels and its effect on plasma renin concentration
DT Fei, WF Graham, JG McDougal, BA Scoggins, JP Coghlan
Life Sciences 1980
A comparison of angiotensin II and angiotensin III as vasoconstrictors in the mesenteric circulation of dogs
SL Britton, JM Sexton, MJ Fiksen-Olsen, PG Werness, JC Romero
Circulation research 1980
Activity of [des-Aspartyl1]-Angiotensin II in Primary Aldosteronism
RM Carey, CR Ayers, ED Vaughan, MJ Peach, SM Herf
Journal of Clinical Investigation 1979
Response of adrenal steroids to angiotensin II in essential hypertension
U Yasuhisa, H Masanobu, H Michinobu
Journal of Steroid Biochemistry 1979
The effect of converting enzyme inhibition with SQ20,881 on plasma and urinary kinins, prostaglandin E, and angiotensin II in hypertensive man
JM Vinci, D Horwitz, RM Zusman, JJ Pisano, KJ Catt, HR Keiser
Hypertension 1979

← Previous 1 2 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts